What This Means for You
- More than 500 new jobs are expected in Montgomery County over the next 12 years.
- The state will provide up to $41.5 million in financial support to secure the project.
- Nearly 5,900 existing Pennsylvania jobs tied to the company are expected to be retained.
SPRING HOUSE, PA — A new cancer-treatment manufacturing facility is coming to Montgomery County following a commitment of more than $1 billion in private investment from Johnson & Johnson, supported by $41.5 million in state funding.
Governor Josh Shapiro and Department of Community & Economic Development Secretary Rick Siger announced the project Wednesday, describing it as a major expansion of Pennsylvania’s life sciences sector.
The facility will be built in Lower Gwynedd Township and operated by Janssen Biotech, a Johnson & Johnson subsidiary. It will manufacture “cell therapy” treatments — a type of advanced medicine that uses a patient’s own modified cells to fight diseases such as cancer.
State Incentives Explained
To secure the project, the Commonwealth offered a package of financial incentives totaling up to $41.5 million.
The incentives include tax credits through the Qualified Manufacturing Innovation and Reinvestment Deduction program, which reduces a company’s tax burden for major manufacturing investments, and the Manufacturing Tax Credit program, which supports job creation in manufacturing.
The state also committed grants through the Pennsylvania First program, which provides funding to companies that create and retain jobs, and the PA SITES program, which helps prepare land for business development.
Additionally, up to $2.5 million from the Redevelopment Assistance Capital Program may be directed to a local community college or technical school to develop workforce training programs tied to the facility.
Economic Impact
The expansion is expected to create more than 500 new jobs over the next 12 years and help retain 5,885 existing full-time positions statewide.
Johnson & Johnson operates 10 facilities across Pennsylvania and generates an estimated $10 billion in annual economic impact statewide. The company said the new site will support the production of medicines for cancer and other serious diseases.
Next Steps
Construction timelines were not specified in the announcement. State officials said the project was coordinated through BusinessPA and supported by the PA Permit Fast Track Program, which aims to streamline permitting for large-scale economic development projects.
The company must meet job-creation and investment benchmarks to receive the full amount of state incentives.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.